Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Jul 29, 2021 $56.29 $59.94 $54.08 $58.47 325 618
Jul 28, 2021 $49.78 $57.07 $49.78 $55.56 250 392
Jul 27, 2021 $52.44 $53.49 $49.10 $49.92 291 271
Jul 26, 2021 $53.00 $54.94 $51.58 $52.52 219 834
Jul 23, 2021 $51.50 $52.45 $50.38 $52.29 319 664
Jul 22, 2021 $53.54 $54.31 $49.12 $52.13 635 548
Jul 21, 2021 $50.72 $56.22 $49.10 $54.19 400 605
Jul 20, 2021 $51.45 $53.47 $49.41 $50.86 486 059
Jul 19, 2021 $49.01 $51.23 $48.09 $51.08 480 455
Jul 16, 2021 $46.80 $51.44 $46.57 $48.57 796 611
Jul 15, 2021 $51.17 $51.17 $46.15 $46.67 321 511
Jul 14, 2021 $53.76 $53.95 $49.36 $49.73 468 025
Jul 13, 2021 $48.40 $57.57 $48.20 $53.15 963 483
Jul 12, 2021 $47.03 $49.03 $46.89 $48.20 378 666
Jul 09, 2021 $46.70 $47.40 $45.01 $46.00 201 380
Jul 08, 2021 $46.29 $47.99 $45.51 $46.25 279 541
Jul 07, 2021 $48.20 $49.51 $46.87 $47.84 144 621
Jul 06, 2021 $49.84 $49.99 $45.90 $47.72 337 695
Jul 02, 2021 $53.16 $56.00 $49.98 $50.14 336 606
Jul 01, 2021 $62.00 $66.60 $52.00 $53.14 748 260
Jun 30, 2021 $58.52 $73.80 $57.93 $60.25 1 582 626
Jun 29, 2021 $44.82 $55.38 $43.10 $54.25 929 669
Jun 28, 2021 $41.96 $48.86 $41.88 $45.00 1 479 206
Jun 25, 2021 $36.56 $37.29 $35.30 $35.99 214 908
Jun 24, 2021 $37.52 $38.77 $35.90 $36.39 432 643
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT